Managing idiopathic Parkinson's disease in patients with schizophrenic disorders

被引：10
作者：
Friedman, Joseph H. [1 ,2 ]
机构：
[1] Butler Hosp, Movement Disorders Program, Providence, RI 02903 USA
[2] Brown Univ, Dept Neurol, Alpert Med Sch, Providence, RI 02912 USA
来源：
PARKINSONISM & RELATED DISORDERS | 2011年 / 17卷 / 03期
关键词：
Parkinson's disease; Schizophrenia; Secondary parkinsonism; Dopaminergic drugs; Atypical antipsychotic drugs; Psychosis; Primary psychosis; Secondary psychosis; FOLLOW-UP; L-DOPA;
D O I：
10.1016/j.parkreldis.2010.11.019
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
There is very little data on the treatment of idiopathic Parkinson's disease (IPD) in patients with schizophrenia. Since schizophrenia is treated primarily with dopamine receptor blocking medications, it is unknown if the beneficial effects of anti-PD medications might be blocked or if the drugs may trigger worsened psychosis. A chart review was performed which identified nine patients with schizophrenia and presumed Idiopathic Parkinson's Disease (IPD). None of the patients suffered worsened psychosis from L-Dopa or a dopamine agonist if taking antipsychotics, and motor response did not appear blunted. (C) 2010 Published by Elsevier Ltd.
引用
收藏
页码：198 / 200
页数：3
相关论文
共 11 条
  • [1] BEHAVIORAL EFFECTS OF L-DOPA IN SCHIZOPHRENIC PATIENTS
    ANGRIST, B
    SATHANANTHAN, G
    GERSHON, S
    [J]. PSYCHOPHARMACOLOGIA, 1973, 31 (01): : 1 - 12
  • [2] The management of psychosis in movement disorder patients
    Chou, Kelvin L.
    Borek, Leora L.
    Friedman, Joseph H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 935 - 943
  • [3] Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease
    Friedman, JH
    Fernandez, HH
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (02) : 120 - 121
  • [4] HABERMAYER S, 2008, J NEUROPSYCHIATRY CL, V20, P373
  • [5] The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
    Howes, Oliver D.
    Kapur, Shitij
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 (03) : 549 - 562
  • [6] HUBBLE JP, 2004, MOVEMENT DISORDERS N, P395
  • [7] KLAWANS HL, 1973, CONFIN NEUROL, V35, P368
  • [8] CHRONIC-SCHIZOPHRENIA AND IDIOPATHIC PARKINSONS-DISEASE
    LAM, RW
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1993, 38 (02): : 75 - 77
  • [9] [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease
    Lorberboym, M
    Treves, TA
    Melamed, E
    Lampl, Y
    Hellmann, M
    Djaldetti, R
    [J]. MOVEMENT DISORDERS, 2006, 21 (04) : 510 - 514
  • [10] Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism
    Tinazzi, Michele
    Antonini, Angelo
    Bovi, Tommaso
    Pasquin, Isabella
    Steinmayr, Maria
    Moretto, Giuseppe
    Fiaschi, Antonio
    Ottaviani, Sarah
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 (06) : 910 - 915
12